Marksans Pharma consolidated net profit rises 169.50% in the June 2026 quarter

Sales rise 35.62% to Rs 840.80 crore
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.